William H. Koster
Chairman presso eXIthera Pharmaceuticals, Inc.
Profilo
William H.
Koster is currently the Chairman at eXIthera Pharmaceuticals, Inc. and the Vice Chairman at Ocuterra Therapeutics, Inc. He previously served as the Executive Chairman at Elicio Therapeutics, Inc. (Old), Director at Neurogen Corp., Director at Cadus Corp., Director at Phytomedics, Inc., Director at Robert Wood Johnson Health Care Corp., Director at Cadent Therapeutics, Inc., SVP-Science, Technology Strategy & Acquisition at Bristol Myers Squibb Co., Principal at Squibb Institute for Medical Research, and Strategic Advisor at Access BridgeGap Ventures.
He obtained his undergraduate degree from Colby College in 1966 and his doctorate degree from Tufts University in 1972.
Posizioni attive di William H. Koster
Società | Posizione | Inizio |
---|---|---|
eXIthera Pharmaceuticals, Inc.
eXIthera Pharmaceuticals, Inc. BiotechnologyHealth Technology eXIthera Pharmaceuticals, Inc. develops and manufactures stroke prevention and antithrombosis drugs. Its drugs are based on the pathophysiological role of Factor XI in the initiation of intravascular thrombi without causing undue bleeding. The firm’s drug candidates are small, orally active, and highly selective Factor XI inhibitors. The company was founded by Neil J. Hayward and Frans L. Stassen in 2012 and is headquartered in Westborough, MA. | Chairman | - |
Ocuterra Therapeutics, Inc.
Ocuterra Therapeutics, Inc. Drugstore ChainsRetail Trade Ocuterra Therapeutics, Inc. manufactures drug products. The company is headquartered in Boston, MA. | Director/Board Member | - |
Precedenti posizioni note di William H. Koster
Società | Posizione | Fine |
---|---|---|
Access BridgeGap Ventures
Access BridgeGap Ventures Investment ManagersFinance Founded in 2011, Access BridgeGap Ventures is a venture capital firm located in Cambridge, Massachusetts. The firm is the life sciences venture capital investment arm of Access Industries, Inc. | Corporate Officer/Principal | 10/10/2013 |
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | Chief Executive Officer | 04/02/2008 |
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Chairman | 09/01/2017 |
Squibb Institute for Medical Research | Corporate Officer/Principal | - |
Phytomedics, Inc.
Phytomedics, Inc. Pharmaceuticals: OtherHealth Technology Phytomedics, Inc. discovers, develops, and manufactures botanical therapeutics using proprietary platform technologies. The company was founded in December 1996 by Ilya Raskin and is headquartered in Jamesburg, NJ. | Director/Board Member | - |
Formazione di William H. Koster
Colby College | Undergraduate Degree |
Tufts University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Aziende private | 10 |
---|---|
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | Health Technology |
Cadus Corp.
Cadus Corp. BiotechnologyHealth Technology Cadus Corp. engages in the acquisition, renovation and construction of real estate. It intends to purchase individual homes or individual residential lots for purposes of renovation or construction and resale. The company was founded by Dana M. Fowlkes, James R. Broach, and Thomas Shenk on January 23, 1992 and is headquartered in New York, NY. | Health Technology |
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Health Technology |
eXIthera Pharmaceuticals, Inc.
eXIthera Pharmaceuticals, Inc. BiotechnologyHealth Technology eXIthera Pharmaceuticals, Inc. develops and manufactures stroke prevention and antithrombosis drugs. Its drugs are based on the pathophysiological role of Factor XI in the initiation of intravascular thrombi without causing undue bleeding. The firm’s drug candidates are small, orally active, and highly selective Factor XI inhibitors. The company was founded by Neil J. Hayward and Frans L. Stassen in 2012 and is headquartered in Westborough, MA. | Health Technology |
Phytomedics, Inc.
Phytomedics, Inc. Pharmaceuticals: OtherHealth Technology Phytomedics, Inc. discovers, develops, and manufactures botanical therapeutics using proprietary platform technologies. The company was founded in December 1996 by Ilya Raskin and is headquartered in Jamesburg, NJ. | Health Technology |
Robert Wood Johnson Health Care Corp. | |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | Health Technology |
Squibb Institute for Medical Research | |
Ocuterra Therapeutics, Inc.
Ocuterra Therapeutics, Inc. Drugstore ChainsRetail Trade Ocuterra Therapeutics, Inc. manufactures drug products. The company is headquartered in Boston, MA. | Retail Trade |
Access BridgeGap Ventures
Access BridgeGap Ventures Investment ManagersFinance Founded in 2011, Access BridgeGap Ventures is a venture capital firm located in Cambridge, Massachusetts. The firm is the life sciences venture capital investment arm of Access Industries, Inc. | Finance |
- Borsa valori
- Insiders
- William H. Koster